BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.480,29 PKT -6,17 PKT -0,42 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
07.07.20 Holcim buy Goldman Sachs Group Inc.
07.07.20 UBS neutral RBC Capital Markets
07.07.20 UBS Outperform Credit Suisse Group
07.07.20 Holcim overweight JP Morgan Chase & Co.
07.07.20 UBS Neutral UBS AG
07.07.20 Swiss Re overweight JP Morgan Chase & Co.
06.07.20 ABB (Asea Brown Boveri) Underweight JP Morgan Chase & Co.
06.07.20 Givaudan Underperform Credit Suisse Group
03.07.20 Holcim buy Goldman Sachs Group Inc.
03.07.20 Holcim overweight Morgan Stanley
02.07.20 Holcim kaufen Credit Suisse Group
02.07.20 Givaudan Neutral JP Morgan Chase & Co.
02.07.20 Nestlé overweight JP Morgan Chase & Co.
01.07.20 Zurich Insurance overweight Barclays Capital
01.07.20 Swiss Re overweight Barclays Capital
01.07.20 Givaudan Hold Deutsche Bank AG
01.07.20 Roche overweight JP Morgan Chase & Co.
30.06.20 Givaudan Neutral JP Morgan Chase & Co.
29.06.20 Nestlé overweight Barclays Capital
29.06.20 Roche overweight JP Morgan Chase & Co.
29.06.20 Nestlé buy UBS AG
25.06.20 Roche Neutral Credit Suisse Group
25.06.20 UBS buy Deutsche Bank AG
25.06.20 Novartis Neutral UBS AG
25.06.20 Roche overweight JP Morgan Chase & Co.
23.06.20 Swiss Re buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
22.06.20 UBS buy Kepler Cheuvreux
22.06.20 UBS Hold Kepler Cheuvreux
22.06.20 Roche buy Oddo BHF
22.06.20 Novartis buy Oddo BHF
19.06.20 Roche overweight JP Morgan Chase & Co.
19.06.20 Roche Conviction Buy Goldman Sachs Group Inc.
18.06.20 Roche Conviction Buy List Goldman Sachs Group Inc.
18.06.20 Zurich Insurance overweight JP Morgan Chase & Co.
18.06.20 Nestlé overweight JP Morgan Chase & Co.
17.06.20 UBS buy UBS AG
16.06.20 Nestlé buy Goldman Sachs Group Inc.
16.06.20 UBS overweight JP Morgan Chase & Co.
16.06.20 UBS Neutral JP Morgan Chase & Co.
16.06.20 UBS Underweight Barclays Capital